| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |